Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory breast cancer: The pathologists' perspective.

G Cserni1, E Charafe-Jauffret2, P J van Diest3

  • 1Bács-Kiskun County Teaching Hospital, Department of Pathology, Nyíri út 38, H6000, Kecskemét, Hungary; University of Szeged, Albert Szent-Györgyi Medical Centre, Department of Pathology, Állomás u. 1, H6725, Szeged, Hungary.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
|May 1, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Tumor infiltrating lymphocytes and change in tumor load on MRI to assess response and prognosis after neoadjuvant chemotherapy in breast cancer.

Breast cancer research and treatment·2024
Same author

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.

Immuno-oncology technology·2024
Same author

Author Correction: Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial.

Nature cancer·2024
Same author

Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial.

Nature cancer·2024
Same author

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.

ESMO open·2024
This summary is machine-generated.

Inflammatory breast cancer (IBC) is a rare but aggressive cancer. Pathologists review diagnostic criteria, staging, and unique molecular features of IBC, highlighting the importance of preclinical models for future research.

Area of Science:

  • Oncology
  • Pathology

Background:

  • Inflammatory breast cancer (IBC) is a distinct clinico-pathological entity characterized by inflammation and dermal lymphatic invasion.
  • IBC presents unique diagnostic challenges and has a generally poor prognosis, necessitating a thorough pathological evaluation.

Purpose of the Study:

  • To provide a pathologist's perspective on Inflammatory Breast Cancer.
  • To summarize diagnostic criteria, differential diagnoses, and staging implications for IBC.
  • To explore the heterogeneity, molecular features, carcinogenetic pathways, and role of the tumor microenvironment in IBC.

Main Methods:

  • Review of existing literature and pathological data on Inflammatory Breast Cancer.
  • Analysis of diagnostic criteria, prognostic factors, and molecular characteristics.
Keywords:
DiagnosisInflammationInflammatory breast cancerMicroenvironmentMolecular backgroundStaging

Related Experiment Videos

  • Discussion of carcinogenetic pathways, inflammatory processes, and cancer stem cell involvement.

    • Main Results:

    • IBC diagnosis relies on specific inflammatory and pathological features, often involving dermal lymphatics.
    • Despite poor prognosis, IBC exhibits heterogeneity in histological type, grade, receptor status, and intrinsic subtype.
    • Unique molecular features may aid in identifying IBC at the molecular level, and the tumor microenvironment is a critical factor.

    Conclusions:

    • Accurate pathological diagnosis and understanding of IBC heterogeneity are crucial.
    • Further research into unique molecular features and the tumor microenvironment is essential for developing effective preclinical models and therapeutic strategies.
    • Preclinical models incorporating stromal and microenvironmental elements are vital for advancing IBC research due to its rarity.